Exagan

Exagen is a commercial-stage life science company focused on developing and marketing high-value diagnostic tests for patients with autoimmune and inflammatory diseases. The company's flagship AVISE portfolio includes tests for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other connective tissue diseases. By leveraging its proprietary Cell-Bound Complement Activation Products (CB-CAPs) technology, Exagen provides clinicians with objective data to improve the speed and accuracy of diagnosis and monitoring. The company is headquartered in Vista, California, and is dedicated to transforming the care continuum for patients suffering from complex autoimmune conditions.